Compare BVS & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BVS | NBB |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | 950 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.4M | 478.5M |
| IPO Year | 2021 | N/A |
| Metric | BVS | NBB |
|---|---|---|
| Price | $7.55 | $16.22 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.33 | N/A |
| AVG Volume (30 Days) | ★ 402.9K | 73.9K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.64% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $563,829,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.22 | N/A |
| P/E Ratio | $49.42 | ★ N/A |
| Revenue Growth | ★ 1.58 | N/A |
| 52 Week Low | $5.81 | $13.67 |
| 52 Week High | $12.53 | $16.66 |
| Indicator | BVS | NBB |
|---|---|---|
| Relative Strength Index (RSI) | 56.48 | 50.27 |
| Support Level | $7.30 | $15.91 |
| Resistance Level | $7.80 | $16.18 |
| Average True Range (ATR) | 0.37 | 0.18 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 81.95 | 54.24 |
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.